| 000 | 01195 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250515125258.0 | ||
| 264 | 0 | _c20090223 | |
| 008 | 200902s 0 0 eng d | ||
| 022 | _a0163-7258 | ||
| 024 | 7 |
_a10.1016/j.pharmthera.2008.04.009 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWesterveld, H E | |
| 245 | 0 | 0 |
_aCardiometabolic abnormalities in the polycystic ovary syndrome: pharmacotherapeutic insights. _h[electronic resource] |
| 260 |
_bPharmacology & therapeutics _cSep 2008 |
||
| 300 |
_a223-41 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAnovulation _xcomplications |
| 650 | 0 | 4 |
_aDyslipidemias _xcomplications |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyperandrogenism _xcomplications |
| 650 | 0 | 4 | _aModels, Biological |
| 650 | 0 | 4 |
_aPolycystic Ovary Syndrome _xcomplications |
| 700 | 1 | _aHoogendoorn, M | |
| 700 | 1 | _ade Jong, A W F | |
| 700 | 1 | _aGoverde, A J | |
| 700 | 1 | _aFauser, B C J M | |
| 700 | 1 | _aDallinga-Thie, G M | |
| 773 | 0 |
_tPharmacology & therapeutics _gvol. 119 _gno. 3 _gp. 223-41 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.pharmthera.2008.04.009 _zAvailable from publisher's website |
| 999 |
_c18085272 _d18085272 |
||